Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VAXX | Class A common stock | Conversion of derivative security | +2.29M | 2.29M | Nov 15, 2021 | Held by COVAXX PML SPV 1 LP | F1, F2, F7 | |||
transaction | VAXX | Class A common stock | Conversion of derivative security | +862K | 862K | Nov 15, 2021 | Held by COVAXX PML SPV 2 LP | F1, F3, F7 | |||
transaction | VAXX | Class A common stock | Conversion of derivative security | +1.52M | 1.52M | Nov 15, 2021 | Held by COVAXX PML SPV 3 LP | F1, F4, F7 | |||
transaction | VAXX | Class A common stock | Conversion of derivative security | +3.62M | 3.62M | Nov 15, 2021 | Held by Prime Movers Growth Fund 1 LP | F1, F5, F7 | |||
transaction | VAXX | Class A common stock | Conversion of derivative security | +9.74M | 9.74M | Nov 15, 2021 | Direct | F1, F6, F7 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VAXX | Series A preferred stock | Conversion of derivative security | -3.57M | -100% | 0 | Nov 15, 2021 | Class A common stock | 2.29M | Held by COVAXX PML SPV 1 LP | F1, F2, F7 | |||
transaction | VAXX | Series A preferred stock | Conversion of derivative security | -1.34M | -100% | 0 | Nov 15, 2021 | Class A common stock | 862K | Held by COVAXX PML SPV 2 LP | F1, F3, F7 | |||
transaction | VAXX | Series A preferred stock | Conversion of derivative security | -2.36M | -100% | 0 | Nov 15, 2021 | Class A common stock | 1.52M | Held by COVAXX PML SPV 3 LP | F1, F4, F7 | |||
transaction | VAXX | Series B preferred stock | Conversion of derivative security | -5.63M | -100% | 0 | Nov 15, 2021 | Class A common stock | 3.62M | Held by Prime Movers Growth Fund 1 LP | F1, F5, F7 | |||
transaction | VAXX | Series A preferred stock | Conversion of derivative security | -15.2M | -100% | 0 | Nov 15, 2021 | Class A common stock | 9.74M | Direct | F1, F6, F7 |
Id | Content |
---|---|
F1 | Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock. |
F2 | Held by COVAXX PML SPV 1 LP ("PML SPV 1"). Prime Movers Lab GP I LLC ("PML GP I") is the general partner of Prime Movers Lab Fund I LP ("PML") and PML SPV 1. |
F3 | Held by COVAXX PML SPV 2 LP ("PML SPV 2"). Prime Movers Lab GP II LLC ("PML GP II") is the general partner of PML SPV 2. |
F4 | Held by COVAXX PML SPV 3 LP ("PML SPV 3"). PML GP II is the general partner of PML SPV 3. |
F5 | Held by Prime Movers Growth Fund 1 LP ("PMG"). Prime Movers Growth GP I LLC ("PMG GP") is the general partner of PMG. |
F6 | Held by PML. PML GP I is the general partner of PML. |
F7 | Dakin Sloss is the manager of PML GP I, PML GP II and PMG GP, and may be deemed to beneficially own the securities held by PML, PMG, PML SPV 1, PML SPV 2 and PML SPV 3. Mr. Sloss disclaims any beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein. |